Active-ingredient Dossier
Diclofenac Sodium
Active-ingredient Dossier for Diclofenac Sodium (nonsteroidal anti-inflammatory drug). Australian brands, products, PBS listings, PBAC outcomes —…
- Brand: FENAC EC
- Brand: SOLARAZE
- Brand: DICLOFENAC SANDOZ
- Brand: DICLOFENAC-WGR
- Brand: VOLTAREN
- Brand: ZICTHORU
- Therapeutic area: Pain Management
- Therapeutic area: Musculoskeletal
- Therapeutic area: Dermatology
What is
Diclofenac Sodium Diclofenac Sodium is a nonsteroidal anti-inflammatory drug.
Australian brands containing
Diclofenac Sodium — FENAC EC — SOLARAZE — CLONAC — DICLOFENAC SANDOZ — DICLOFENAC-WGR — VOLTAREN — ZICTHORU
Therapeutic areas
Diclofenac Sodium is registered across four therapeutic areas: Immunology (8 brands), Pain & Anaesthesia (3 brands), Dermatology (2 brands), and Women's Health (1 brand).
Sponsor landscape
The ingredient is marketed by ten sponsors, including Medreich, Sandoz, Arrotex Pharmaceuticals, GM Pharma, Glenmark Pharmaceuticals, and Alphapharm.
PBS and regulatory activity
Two brands containing Diclofenac Sodium have PBS-listed items, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome on record is from 1 November 2009, with one brand holding a recorded PBAC outcome. No AusPARs are currently on record for this ingredient.